Turberville Antonia, Semple Hannah, Davies Gareth, Ivanov Delyan, Holdgate Geoffrey A
High-throughput Screening, Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, United Kingdom.
High-throughput Screening, Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, United Kingdom.
SLAS Discov. 2022 Dec;27(8):419-427. doi: 10.1016/j.slasd.2022.09.001. Epub 2022 Sep 9.
Enzyme activation remains a largely under-represented and poorly exploited area of drug discovery despite some key literature examples of the successful application of enzyme activators by various mechanisms and their importance in a wide range of therapeutic interventions. Here we describe the background nomenclature, present the current position of this field of drug discovery and discuss the challenges of hit identification for enzyme activation, as well as our perspectives on the approaches needed to overcome these challenges in early drug discovery.
尽管有一些关键的文献实例表明,通过各种机制成功应用酶激活剂,以及它们在广泛的治疗干预中的重要性,但酶激活在药物发现领域仍然是一个代表性不足且利用不佳的领域。在此,我们描述了相关的背景术语,介绍了该药物发现领域的现状,并讨论了酶激活的活性分子识别面临的挑战,以及我们对在早期药物发现中克服这些挑战所需方法的看法。